Evidence map›Paper›PMID 23940704›Full record

ArticlePloS one2013

Requirement for the eIF4E binding proteins for the synergistic down-regulation of protein synthesis by hypertonic conditions and mTOR inhibition.

Michael J Clemens, Androulla Elia, Simon J Morley

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michael J ClemensDepartment of Biochemistry and Molecular Biology, School of Life Sciences, University of Sussex, JMS Building, Falmer, Brighton, United Kingdom.
Androulla Elia
Simon J Morley
University of Sussex · GBSt George's, University of London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H018956Wellcome Trust
6 · The paper itself

Abstract

The protein kinase mammalian target of rapamycin (mTOR) regulates the phosphorylation and activity of several proteins that have the potential to control translation, including p70S6 kinase and the eIF4E binding proteins 4E-BP1 and 4E-BP2. In spite of this, in exponentially growing cells overall protein synthesis is often resistant to mTOR inhibitors. We report here that sensitivity of wild-type mouse embryonic fibroblasts (MEFs) to mTOR inhibitors can be greatly increased when the cells are subjected to the physiological stress imposed by hypertonic conditions. In contrast, protein synthesis in MEFs with a double knockout of 4E-BP1 and 4E-BP2 remains resistant to mTOR inhibitors under these conditions. Phosphorylation of p70S6 kinase and protein kinase B (Akt) is blocked by the mTOR inhibitor Ku0063794 equally well in both wild-type and 4E-BP knockout cells, under both normal and hypertonic conditions. The response of protein synthesis to hypertonic stress itself does not require the 4E-BPs. These data suggest that under certain stress conditions: (i) translation has a greater requirement for mTOR activity and (ii) there is an absolute requirement for the 4E-BPs for regulation by mTOR. Importantly, dephosphorylation of p70S6 kinase and Akt is not sufficient to affect protein synthesis acutely.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarrier ProteinsCell Cycle ProteinsCells, CulturedDown-RegulationEukaryotic Initiation Factor-4EEukaryotic Initiation FactorsFuransMiceMorpholinesPhosphoproteinsProtein BiosynthesisPyridinesPyrimidinesSaline Solution, HypertonicAdaptor Proteins, Signal TransducingCarrier ProteinsCell Cycle ProteinsEif4ebp1 protein, mouseEif4ebp2 protein, mouseEukaryotic Initiation Factor-4EEukaryotic Initiation FactorsFuransKu 0063794MorpholinesmTOR protein, mousePhosphoproteinsPI103PyridinesPyrimidinesSaline Solution, HypertonicTOR Serine-Threonine Kinases

Identifiers

PMID23940704
PMCPMC3733773
OpenAlexW2148558359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.